Letko, Brosseau & Associates’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,651,100
Closed -$13.8M 103
2022
Q2
$13.8M Buy
1,651,100
+309,700
+23% +$4.33M 0.24% 73
2022
Q1
$30.7M Buy
1,341,400
+70,075
+6% +$1.71M 0.46% 67
2021
Q4
$35.2M Buy
1,271,325
+107,125
+9% +$2.87M 0.5% 60
2021
Q3
$32.5M Buy
+1,164,200
New +$33M 0.47% 62

Other funds holding BHC

Letko, Brosseau & Associates's BHC Position: Q3 2022 in Review

Letko, Brosseau & Associates sold out of Bausch Health (BHC) in Q3 2022, closing a stake of 1,651,100 shares — an estimated $13.8M sold.

Letko, Brosseau & Associates first reported a position in BHC in Q3 2021 and held it in 4 quarters. The position peaked at $35.2M in Q4 2021. 283 funds tracked by Wall St. Rank hold BHC as of Q3 2022.

  • Letko, Brosseau & Associates reported no remaining Bausch Health position as of Q3 2022 after selling out during the quarter.
  • Letko, Brosseau & Associates sold 1,651,100 Bausch Health shares in Q3 2022, an estimated $13.8M.
  • Letko, Brosseau & Associates first reported a position in Bausch Health in Q3 2021 and held it in 4 quarters.
  • Letko, Brosseau & Associates's Bausch Health position peaked at $35.2M in Q4 2021.
  • 283 funds tracked by Wall St. Rank held Bausch Health as of Q3 2022.

Based on Letko, Brosseau & Associates's 13F filing for Q3 2022, filed 10 Nov 2022.